Back to User profile » Dr Matthew Fyfe
Paper published by Dr Matthew Fyfe:
Clinical Trial Report
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
Taylor M, Ousler G, Torkildsen G, Walshe C, Fyfe MCT, Rowley A, Webber S, Sheppard JD, Duggal A
Clinical Ophthalmology 2019, 13:261-275
Published Date: 12 February 2019